Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals

References

• de Wit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981;75:134–143
   PubMed Web of Science ®Google Scholar
• Meil WM, See RE. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol 1996;7:754–763
   Google Scholar
• Erb S, Shaham Y, Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) 1996;128:408–412
   PubMed Web of Science ®Google Scholar
• Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O’Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 1993;137:73–95
   PubMedGoogle Scholar
• McKay JR, Rutherford MJ, Alterman AI, Cacciola JS, Kaplan MR. An examination of the cocaine relapse process. Drug Alcohol Depend 1995;38:35–43
   PubMed Web of Science ®Google Scholar
• Sinha R, Catapano D, O’Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology 1999;142:343–351
   PubMed Web of Science ®Google Scholar
• Sinha R, Fuse T, Aubin LR, O’Malley SS. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 2000;152:140–148
   PubMed Web of Science ®Google Scholar
• Feltenstein MW, See RE. Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res 2006;174:1–8
   PubMed Web of Science ®Google Scholar
• Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 2003;170:62–72
   PubMed Web of Science ®Google Scholar
• Harris GC, Aston-Jones G. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology (Berl) 1993;113:131–136
   PubMed Web of Science ®Google Scholar
• Rudoy CA, Van Bockstaele EJ. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuro-Psychopharmacol Biolog Psychiatry 2007;31:1119–1129
   Google Scholar
• McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 1994;51:713–719
   PubMed Web of Science ®Google Scholar
• Shepard JD, Bossert JM, Liu SY, Shaham Y. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biolog Psychiatry 2004;55:1082–1089
   PubMed Web of Science ®Google Scholar
• Brown ZJ, Tribe E, D’Souza N A, Erb S. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 2009;203:121–130
   PubMed Web of Science ®Google Scholar
• Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 2000;23:138–150
   PubMed Web of Science ®Google Scholar
• Ernsberger P, Giuliano R, Willette RN, Reis DJ. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Experim Therapeut 1990;253:408–418
   PubMed Web of Science ®Google Scholar
• Sorkin EM, Heel RC. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 1986;31:301–336
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Scahill L, Findling RL. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolescent Psychopharmacol 2007;17:393–406
   PubMed Web of Science ®Google Scholar
• Sinha R, Kimmerling A, Doebrick C, Kosten TR. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) 2007;190:569–574
   PubMed Web of Science ®Google Scholar
• Aoki C, Go CG, Venkatesan C, Kurose H. Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res 1994;650:181–204
   PubMed Web of Science ®Google Scholar
• Talley EM, Rosin DL, Lee A, Guyenet PG, Lynch KR. Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comparative Neurol 1996;372:111–134
   Google Scholar
• Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A, Morgan PT, Sinha R. Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings. J Psychopharmacol 2012;26:958–972
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–33;quiz 34–57
   PubMed Web of Science ®Google Scholar
• First MB, Frances AJ, Pincus HA, Vettorello N, Davis WW. DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. Hosp Community Psychiatry 1994;45:18–20
   PubMedGoogle Scholar
• Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006;81:313–322
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 2003;71:207–211
   PubMed Web of Science ®Google Scholar
• Jakala P, Riekkinen M, Sirvio J, Koivisto E, Kejonen K, Vanhanen M, Riekkinen P Jr. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 1999;20:460–470
   PubMedGoogle Scholar
• Jakala P, Sirvio J, Riekkinen M, Koivisto E, Kejonen K, Vanhanen M, Riekkinen P Jr. Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans. Neuropsychopharmacology 1999;20:119–130
   PubMed Web of Science ®Google Scholar
• Coull JT, Nobre AC, Frith CD. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex 2001;11:73–84
   PubMed Web of Science ®Google Scholar
• Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’ – a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76–81
   PubMed Web of Science ®Google Scholar
• Saladin ME, Drobes DJ, Coffey SF, Dansky BS, Brady KT, Kilpatrick DG. PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime. Addict Behav 2003;28:1611–1629
   PubMed Web of Science ®Google Scholar
• Coffey SF, Saladin ME, Drobes DJ, Brady KT, Dansky BS, Kilpatrick DG. Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence. Drug Alcohol Depend 2002;65:115–127
   PubMed Web of Science ®Google Scholar
• Fox HC, Morgan PT, Sinha R. Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals. Neuropsychopharmacology 2014;39:1527--1537
   Google Scholar
• Buffalari DM, See RE. Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse. Physiol Behav 2009;98:614–617
   PubMed Web of Science ®Google Scholar
• Feltenstein MW, Henderson AR, See RE. Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (Berl) 2011;216:53–62
   Google Scholar
• McCance-Katz EF, Carroll KM, Rounsaville BJ. Gender differences in treatment-seeking cocaine abusers – implications for treatment and prognosis. Am J Addict 1999;8:300–311
   PubMed Web of Science ®Google Scholar
• Waldrop AE, Price KL, Desantis SM, Simpson AN, Back SE, McRae AL, Spratt EG, et al. Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cues. Psychoneuroendocrinology 2009;35:798--806
   Google Scholar
• Back SE, Brady KT, Jackson JL, Salstrom S, Zinzow H. Gender differences in stress reactivity among cocaine-dependent individuals. Psychopharmacology 2005;180:169–176
   PubMed Web of Science ®Google Scholar
• McRae-Clark AL, Carter RE, Price KL, Baker NL, Thomas S, Saladin ME, Giarla K, et al. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology 2011;218:49–58
   PubMed Web of Science ®Google Scholar
• Thomas SE, Randall PK, Brady K, See RE, Drobes DJ. An acute psychosocial stressor does not potentiate alcohol cue reactivity in non-treatment-seeking alcoholics. Alcoholism, Clin Experim Res 2011;35:464–473
   PubMedGoogle Scholar
• Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL. Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology 2011;218:83–88
   PubMed Web of Science ®Google Scholar
• Sayette MA, Griffin KM, Sayers WM. Counterbalancing in smoking cue research: a critical analysis. Nicotine Tob Res 2010;12:1068–1079
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addictive Behav 2010;35:1001--1007
   Google Scholar
• Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry 1993;150:1707–1711
   PubMed Web of Science ®Google Scholar